{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:30:17Z","timestamp":1788888617657,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T00:00:00Z","timestamp":1687046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T00:00:00Z","timestamp":1687046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DOC 33-B27"],"award-info":[{"award-number":["DOC 33-B27"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>X-linked adrenoleukodystrophy (X-ALD), the most frequent, inherited peroxisomal disease, is caused by mutations in the <jats:italic>ABCD1<\/jats:italic> gene encoding a peroxisomal lipid transporter importing very long-chain fatty acids (VLCFAs) from the cytosol into peroxisomes for degradation via \u03b2-oxidation. ABCD1 deficiency results in accumulation of VLCFAs in tissues and body fluids of X-ALD patients with a wide range of phenotypic manifestations. The most severe variant, cerebral X-ALD (CALD) is characterized by progressive inflammation, loss of the myelin-producing oligodendrocytes and demyelination of the cerebral white matter. Whether the oligodendrocyte loss and demyelination in CALD are caused by a primary cell autonomous defect or injury to oligodendrocytes or by a secondary effect of the inflammatory reaction remains unresolved. To address the role of X-ALD oligodendrocytes in demyelinating pathophysiology, we combined the <jats:italic>Abcd1<\/jats:italic> deficient X-ALD mouse model, in which VLCFAs accumulate without spontaneous demyelination, with the cuprizone model of toxic demyelination. In mice, the copper chelator cuprizone induces reproducible demyelination in the corpus callosum, followed by remyelination upon cuprizone removal. By immunohistochemical analyses of oligodendrocytes, myelin, axonal damage and microglia activation during de-and remyelination, we found that the mature oligodendrocytes of <jats:italic>Abcd1<\/jats:italic> KO mice are more susceptible to cuprizone-induced cell death compared to WT mice in the early demyelinating phase. Furthermore, this effect was mirrored by a greater extent of acute axonal damage during demyelination in the KO mice. <jats:italic>Abcd1<\/jats:italic> deficiency did not affect the function of microglia in either phase of the treatment. Also, the proliferation and differentiation of oligodendrocyte precursor cells and remyelination progressed at similar rates in both genotypes. Taken together, our findings point to an effect of <jats:italic>Abcd1<\/jats:italic> deficiency on mature oligodendrocytes and the oligodendrocyte-axon unit, leading to increased vulnerability in the context of a demyelinating insult.<\/jats:p>","DOI":"10.1186\/s40478-023-01595-w","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T04:01:28Z","timestamp":1687060888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy"],"prefix":"10.1186","volume":"11","author":[{"given":"Ksenija","family":"Martinovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Forss-Petter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,18]]},"reference":[{"issue":"4","key":"1595_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijns2040015","volume":"2","author":"AB Moser","year":"2016","unstructured":"Moser AB et al (2016) Newborn screening for X-linked adrenoleukodystrophy. Int J Neonatal Screen 2(4):1","journal-title":"Int J Neonatal Screen"},{"issue":"6414","key":"1595_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361(6414):726\u2013730","journal-title":"Nature"},{"issue":"2","key":"1595_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/hmg\/3.2.265","volume":"3","author":"J Mosser","year":"1994","unstructured":"Mosser J et al (1994) The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 3(2):265\u2013271","journal-title":"Hum Mol Genet"},{"issue":"26","key":"1595_CR4","doi-asserted-by":"publisher","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","volume":"288","author":"C Wiesinger","year":"2013","unstructured":"Wiesinger C et al (2013) Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem 288(26):19269\u201319279","journal-title":"J Biol Chem"},{"issue":"Pt 8","key":"1595_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","volume":"120","author":"HW Moser","year":"1997","unstructured":"Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120(Pt 8):1485\u20131508","journal-title":"Brain"},{"issue":"3","key":"1595_CR6","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1006\/bbrc.1994.2855","volume":"205","author":"J Berger","year":"1994","unstructured":"Berger J et al (1994) X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun 205(3):1638\u20131643","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1595_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1023\/A:1022535930009","volume":"24","author":"KD Smith","year":"1999","unstructured":"Smith KD et al (1999) X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem Res 24(4):521\u2013535","journal-title":"Neurochem Res"},{"issue":"2","key":"1595_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","volume":"59","author":"JM Powers","year":"2000","unstructured":"Powers JM et al (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 59(2):89\u2013102","journal-title":"J Neuropathol Exp Neurol"},{"issue":"100","key":"1595_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","volume":"98","author":"J Berger","year":"2014","unstructured":"Berger J, Forss-Petter S, Eichler FS (2014) Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 98(100):135\u2013142","journal-title":"Biochimie"},{"issue":"6","key":"1595_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00005072-199211000-00007","volume":"51","author":"JM Powers","year":"1992","unstructured":"Powers JM et al (1992) The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 51(6):630\u2013643","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"1595_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1750-3639.2010.00391.x","volume":"20","author":"S Kemp","year":"2010","unstructured":"Kemp S, Wanders R (2010) Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 20(4):831\u2013837","journal-title":"Brain Pathol"},{"issue":"4","key":"1595_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1750-3639.2010.00394.x","volume":"20","author":"N Cartier","year":"2010","unstructured":"Cartier N, Aubourg P (2010) Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy. Brain Pathol 20(4):857\u2013862","journal-title":"Brain Pathol"},{"issue":"3","key":"1595_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbmt.2018.09.036","volume":"25","author":"GV Raymond","year":"2019","unstructured":"Raymond GV et al (2019) Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transpl 25(3):538\u2013548","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"1595_CR14","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1093\/hmg\/ddt645","volume":"23","author":"FD Weber","year":"2014","unstructured":"Weber FD et al (2014) X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes. Hum Mol Genet 23(10):2542\u20132550","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1595_CR15","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/brain\/awy127","volume":"141","author":"I Weinhofer","year":"2018","unstructured":"Weinhofer I et al (2018) Impaired plasticity of macrophages in X-linked adrenoleukodystrophy. Brain 141(8):2329\u20132342","journal-title":"Brain"},{"issue":"6","key":"1595_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.21391","volume":"63","author":"FS Eichler","year":"2008","unstructured":"Eichler FS et al (2008) Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 63(6):729\u2013742","journal-title":"Ann Neurol"},{"issue":"6","key":"1595_CR17","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/glia.23598","volume":"67","author":"CG Bergner","year":"2019","unstructured":"Bergner CG et al (2019) Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia 67(6):1196\u20131209","journal-title":"Glia"},{"issue":"10","key":"1595_CR18","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/glia.24042","volume":"69","author":"CG Bergner","year":"2021","unstructured":"Bergner CG et al (2021) Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis. Glia 69(10):2362\u20132377","journal-title":"Glia"},{"issue":"5","key":"1595_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W","volume":"50","author":"S Forss-Petter","year":"1997","unstructured":"Forss-Petter S et al (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50(5):829\u2013843","journal-title":"J Neurosci Res"},{"issue":"17","key":"1595_CR20","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","volume":"94","author":"JF Lu","year":"1997","unstructured":"Lu JF et al (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94(17):9366\u20139371","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1595_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1006\/bbrc.1997.6340","volume":"232","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T et al (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232(3):631\u2013636","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1595_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","volume":"11","author":"A Pujol","year":"2002","unstructured":"Pujol A et al (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11(5):499\u2013505","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1595_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF01102943","volume":"1","author":"WF Blakemore","year":"1972","unstructured":"Blakemore WF (1972) Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol 1(4):413\u2013426","journal-title":"J Neurocytol"},{"issue":"1","key":"1595_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11(1):107\u2013116","journal-title":"Brain Pathol"},{"issue":"1\u20132","key":"1595_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","volume":"92","author":"MM Hiremath","year":"1998","unstructured":"Hiremath MM et al (1998) Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice. J Neuroimmunol 92(1\u20132):38\u201349","journal-title":"J Neuroimmunol"},{"key":"1595_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fncel.2014.00073","volume":"8","author":"V Gudi","year":"2014","unstructured":"Gudi V et al (2014) Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front Cell Neurosci 8:73","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1595_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neulet.2009.02.004","volume":"453","author":"M Lindner","year":"2009","unstructured":"Lindner M et al (2009) Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci Lett 453(2):120\u2013125","journal-title":"Neurosci Lett"},{"issue":"6","key":"1595_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00401-007-0288-4","volume":"114","author":"M Dumser","year":"2007","unstructured":"Dumser M et al (2007) Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1\/Mag deficiency. Acta Neuropathol 114(6):573\u2013586","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1595_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40478-017-0497-6","volume":"5","author":"SA Berghoff","year":"2017","unstructured":"Berghoff SA et al (2017) Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model. Acta Neuropathol Commun 5(1):94","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"1595_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12031-017-0903-3","volume":"61","author":"T Hochstrasser","year":"2017","unstructured":"Hochstrasser T et al (2017) Cuprizone-containing pellets are less potent to induce consistent demyelination in the corpus callosum of C57BL\/6 Mice. J Mol Neurosci 61(4):617\u2013624","journal-title":"J Mol Neurosci"},{"issue":"1","key":"1595_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","volume":"17","author":"M Zirngibl","year":"2022","unstructured":"Zirngibl M et al (2022) Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Mol Neurodegener 17(1):34","journal-title":"Mol Neurodegener"},{"issue":"6","key":"1595_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp M et al (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118(6):723\u2013736","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1595_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff SA et al (2021) Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat Neurosci 24(1):47\u201360","journal-title":"Nat Neurosci"},{"issue":"2","key":"1595_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.nbd.2009.10.016","volume":"37","author":"A Hesse","year":"2010","unstructured":"Hesse A et al (2010) In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis 37(2):362\u2013369","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1595_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","volume":"17","author":"JM Vega-Riquer","year":"2019","unstructured":"Vega-Riquer JM et al (2019) Five decades of Cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol 17(2):129\u2013141","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1595_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jnc.12992","volume":"133","author":"M Baarine","year":"2015","unstructured":"Baarine M et al (2015) ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. J Neurochem 133(3):380\u2013396","journal-title":"J Neurochem"},{"issue":"3","key":"1595_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","volume":"61","author":"JL Mason","year":"2000","unstructured":"Mason JL et al (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination\/remyelination. J Neurosci Res 61(3):251\u2013262","journal-title":"J Neurosci Res"},{"issue":"1","key":"1595_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","volume":"35","author":"S Moyon","year":"2015","unstructured":"Moyon S et al (2015) Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. J Neurosci 35(1):4\u201320","journal-title":"J Neurosci"},{"issue":"12","key":"1595_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJM Franklin","year":"2017","unstructured":"Franklin RJM, Ffrench-Constant C (2017) Regenerating CNS myelin - from mechanisms to experimental medicines. Nat Rev Neurosci 18(12):753\u2013769","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"1595_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1006\/nbdi.2000.0315","volume":"7","author":"V Feigenbaum","year":"2000","unstructured":"Feigenbaum V et al (2000) Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients. Neurobiol Dis 7(6):600\u2013612","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1595_CR41","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/jnen\/60.10.1004","volume":"60","author":"M Ito","year":"2001","unstructured":"Ito M et al (2001) Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 60(10):1004\u20131019","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7408","key":"1595_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487(7408):443\u2013448","journal-title":"Nature"},{"issue":"7399","key":"1595_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U Funfschilling","year":"2012","unstructured":"Funfschilling U et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485(7399):517\u2013521","journal-title":"Nature"},{"issue":"1","key":"1595_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuron.2016.05.016","volume":"91","author":"AS Saab","year":"2016","unstructured":"Saab AS et al (2016) Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 91(1):119\u2013132","journal-title":"Neuron"},{"issue":"5369","key":"1595_CR45","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1126\/science.280.5369.1610","volume":"280","author":"I Griffiths","year":"1998","unstructured":"Griffiths I et al (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280(5369):1610\u20131613","journal-title":"Science"},{"issue":"3","key":"1595_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ng1095","volume":"33","author":"C Lappe-Siefke","year":"2003","unstructured":"Lappe-Siefke C et al (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33(3):366\u2013374","journal-title":"Nat Genet"},{"issue":"4","key":"1595_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/nbdi.1997.0127","volume":"3","author":"F Fouquet","year":"1997","unstructured":"Fouquet F et al (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 3(4):271\u2013285","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1595_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","volume":"32","author":"LA Pasquini","year":"2007","unstructured":"Pasquini LA et al (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32(2):279\u2013292","journal-title":"Neurochem Res"},{"issue":"Pt 2","key":"1595_CR49","first-page":"288","volume":"132","author":"H Neumann","year":"2009","unstructured":"Neumann H, Kotter MR, Franklin RJ (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132(Pt 2):288\u2013295","journal-title":"Brain"},{"issue":"11","key":"1595_CR50","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/acn3.51200","volume":"7","author":"B Zierfuss","year":"2020","unstructured":"Zierfuss B et al (2020) Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275. Ann Clin Transl Neurol 7(11):2161\u20132177","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1595_CR51","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1073\/pnas.93.3.1265","volume":"93","author":"G Lombard-Platet","year":"1996","unstructured":"Lombard-Platet G et al (1996) A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci USA 93(3):1265\u20131269","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1595_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/bbrc.1997.7391","volume":"239","author":"A Holzinger","year":"1997","unstructured":"Holzinger A et al (1997) cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter. Biochem Biophys Res Commun 239(1):261\u2013264","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1595_CR53","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1016\/S0021-9258(19)39595-X","volume":"265","author":"K Kamijo","year":"1990","unstructured":"Kamijo K et al (1990) The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J Biol Chem 265(8):4534\u20134540","journal-title":"J Biol Chem"},{"issue":"3","key":"1595_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbalip.2010.11.010","volume":"1811","author":"CW van Roermund","year":"2011","unstructured":"van Roermund CW et al (2011) Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid beta-oxidation. Biochim Biophys Acta 1811(3):148\u2013152","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1595_CR55","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/hmg\/8.5.907","volume":"8","author":"A Netik","year":"1999","unstructured":"Netik A et al (1999) Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum Mol Genet 8(5):907\u2013913","journal-title":"Hum Mol Genet"},{"issue":"23","key":"1595_CR56","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","volume":"13","author":"A Pujol","year":"2004","unstructured":"Pujol A et al (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13(23):2997\u20133006","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1595_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108655","volume":"9","author":"Z Muneer","year":"2014","unstructured":"Muneer Z et al (2014) Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice. PLoS ONE 9(9):e108655","journal-title":"PLoS ONE"},{"issue":"4","key":"1595_CR58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/nan.12399","volume":"44","author":"AL Gortz","year":"2018","unstructured":"Gortz AL et al (2018) Heat shock protein expression in cerebral X-linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss. Neuropathol Appl Neurobiol 44(4):363\u2013376","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"1595_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1194\/jlr.M800321-JLR200","volume":"50","author":"J Singh","year":"2009","unstructured":"Singh J, Khan M, Singh I (2009) Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. J Lipid Res 50(1):135\u2013147","journal-title":"J Lipid Res"},{"issue":"2","key":"1595_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06228","volume":"7","author":"M Morita","year":"2021","unstructured":"Morita M et al (2021) Generation of an immortalized astrocytic cell line from Abcd1-deficient H-2K(b)tsA58 mice to facilitate the study of the role of astrocytes in X-linked adrenoleukodystrophy. Heliyon 7(2):e06228","journal-title":"Heliyon"},{"issue":"4","key":"1595_CR61","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1750-3639.2010.00392.x","volume":"20","author":"I Singh","year":"2010","unstructured":"Singh I, Pujol A (2010) Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 20(4):838\u2013844","journal-title":"Brain Pathol"},{"issue":"36","key":"1595_CR62","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36):11929\u201311947","journal-title":"J Neurosci"},{"issue":"2","key":"1595_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17(2):210\u2013218","journal-title":"Brain Pathol"},{"issue":"Pt 12","key":"1595_CR64","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios P et al (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129(Pt 12):3165\u20133172","journal-title":"Brain"},{"issue":"6","key":"1595_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11910-021-01110-5","volume":"21","author":"TJ Simkins","year":"2021","unstructured":"Simkins TJ, Duncan GJ, Bourdette D (2021) Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications. Curr Neurol Neurosci Rep 21(6):26","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"1595_CR66","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","volume":"12","author":"I Weinhofer","year":"2021","unstructured":"Weinhofer I et al (2021) Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nat Commun 12(1):1816","journal-title":"Nat Commun"},{"issue":"9","key":"1595_CR67","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE et al (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16(9):1211\u20131218","journal-title":"Nat Neurosci"},{"issue":"1","key":"1595_CR68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","volume":"26","author":"MR Kotter","year":"2006","unstructured":"Kotter MR et al (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26(1):328\u2013332","journal-title":"J Neurosci"},{"issue":"4","key":"1595_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron A et al (2015) Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med 212(4):481\u2013495","journal-title":"J Exp Med"},{"issue":"11","key":"1595_CR70","first-page":"1","volume":"11","author":"S Petrillo","year":"2022","unstructured":"Petrillo S et al (2022) Antioxidant response in human X-linked adrenoleukodystrophy fibroblasts. Antioxidants (Basel) 11(11):1","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"1595_CR71","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.bbalip.2019.02.006","volume":"1864","author":"Q Raas","year":"2019","unstructured":"Raas Q et al (2019) CRISPR\/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy. Biochim Biophys Acta Mol Cell Biol Lipids 1864(5):704\u2013714","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01595-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T05:01:40Z","timestamp":1687064500000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01595-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,18]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01595-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,18]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mouse study was performed in compliance with the national (Austrian) regulations (BGBl. II Nr. 522\/2012) and the European Union directive 2010\/63\/EU. Ethical approval for the study was obtained from the Institutional Animal Care and Use Committee of the Medical University of Vienna and the Austrian Federal Ministry of Science, Research and Economy (BMBWF-66.009\/0174-V\/3b\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}